《大行報告》花旗下調Tesla(TSLA.US)目標價至175美元 評級「中性」
花旗發表研究報告指,美國電動車巨擘Tesla(TSLA.US)首季利潤率低於預期,印證了降價並未達到預期效果,連同最近第二季的降價,或會抑制短期情緒,因為在疲軟的宏觀背景下,隨著集團致力於完成2023年的銷量目標,其利潤率可能會更疲弱。該行預計集團股價將會回落。
該行下維持集團「中性」評級,目標價由192美元下調至175美元。該行估計,第二季持續的汽車毛利率壓力,將隨著銷量增加和成本壓力降低而在下半年出現適度復甦,如果集團需要進一步降價以實現2023年的銷量目標,該行對Tesla的估算或會面臨額外風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.